1.57
Precedente Chiudi:
$1.39
Aprire:
$1.54
Volume 24 ore:
1.30M
Relative Volume:
1.36
Capitalizzazione di mercato:
$155.59M
Reddito:
$624.29M
Utile/perdita netta:
$6.86M
Rapporto P/E:
21.57
EPS:
0.0728
Flusso di cassa netto:
$-74.35M
1 W Prestazione:
+18.05%
1M Prestazione:
+1.29%
6M Prestazione:
-68.85%
1 anno Prestazione:
-56.75%
Docgo Inc Stock (DCGO) Company Profile
Nome
Docgo Inc
Settore
Industria
Telefono
(844) 443-6246
Indirizzo
685 THIRD AVENUE, NEW YORK
Confronta DCGO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DCGO
Docgo Inc
|
1.57 | 139.74M | 624.29M | 6.86M | -74.35M | 0.0728 |
![]()
HCA
Hca Healthcare Inc
|
381.61 | 85.68B | 72.70B | 5.97B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
165.58 | 14.07B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 13.80B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
117.58 | 11.75B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
172.30 | 10.53B | 16.08B | 1.20B | 1.06B | 17.82 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-09 | Downgrade | BTIG Research | Buy → Neutral |
2025-02-28 | Downgrade | Deutsche Bank | Buy → Hold |
2023-08-18 | Iniziato | BTIG Research | Buy |
2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2022-04-19 | Iniziato | Deutsche Bank | Buy |
2022-01-19 | Iniziato | Stifel | Buy |
2021-12-21 | Iniziato | Canaccord Genuity | Buy |
2021-12-07 | Iniziato | Needham | Buy |
Mostra tutto
Docgo Inc Borsa (DCGO) Ultime notizie
What’s the fair value of DocGo Inc. stockHigh Liquidity Trading Alerts - thegnnews.com
DocGo targets over 31,000 care gap visits for 2025 while advancing AI-driven patient engagement - MSN
What makes DocGo Inc. stock price move sharply7-Day High Return Stock Forecast - kangso.co.kr
DocGo (DCGO) Q2 Revenue Falls 51% - AOL.com
DocGo Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
DocGo Inc. (NASDAQ:DCGO) Q2 2025 Earnings Call Transcript - Insider Monkey
DocGo Inc. (DCGO) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
DocGo 2025 Q2 Earnings Significant Earnings Decline Amid Revenue Drop - AInvest
Earnings call transcript: DocGo Q2 2025 misses forecasts amid revenue decline - Investing.com
DocGo Inc.'s Q2 2025: Unpacking Contradictions in Patient Growth, Revenue Projections, and Margin Expectations - AInvest
DocGo Reports Q2 2025 Results Amid Revenue Decline - TipRanks
DocGo (DCGO) Q2 Revenue Falls 51% - The Motley Fool
DocGo Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DocGo reports Q2 EPS (11c), consensus (23c) - TipRanks
DocGo's Revenue Drops Sharply, But Wall Street Remains Optimistic - Finimize
DocGo earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
DocGo's Q2 Earnings: A Tale of Two Metrics and the Road to Recovery - AInvest
DocGo Q2 revenue beats estimates, reiterates 2025 revenue guidance - MarketScreener
DocGo Announces Second Quarter 2025 Results - Business Wire
DocGo secures contract with major NY academic medical system - Investing.com India
DocGo secures contract with major NY academic medical system By Investing.com - Investing.com Nigeria
DocGo to Provide Digital Transportation Management Platform, Dedicated Ambulance Service to Major New York Health System - Bluefield Daily Telegraph
DocGo Inc. Faces Securities Fraud Investigation, $4M in Insider Stock Sales - AInvest
Order Flow Trends Show Accumulation in DocGo Inc.Potential Breakout Stock List Published This Week - metal.it
DocGo faces lawsuit over CEO's educational background and business claims. - AInvest
DocGo Hit With Major Fraud Lawsuit: Judge Rules CEO Education Claims "Indisputably False" - Stock Titan
How volatile is DocGo Inc. stock compared to the marketCapitalize on market trends early - Jammu Links News
Is DocGo Inc. stock overvalued or undervaluedUnlock daily market insights for better trades - Jammu Links News
Should I hold or sell DocGo Inc. stock in 2025Achieve fast wealth growth with smart picks - Jammu Links News
Is it the right time to buy DocGo Inc. stockGame-changing capital returns - Jammu Links News
What are analysts’ price targets for DocGo Inc. in the next 12 monthsAccelerated profit realization - Jammu Links News
Is DocGo Inc. a good long term investmentSuperior stock growth - Jammu Links News
Is DocGo Inc. a growth stock or a value stockHigh-yield portfolio picks - Jammu Links News
How many analysts rate DocGo Inc. as a “Buy”Unmatched profit potential - Jammu Links News
What is DocGo Inc. company’s growth strategyFree Wealth Management Insights - Jammu Links News
What analysts say about DocGo Inc. stockBreakthrough profits - Jammu Links News
What are the technical indicators suggesting about DocGo Inc.Capitalize on emerging trends for profits - Jammu Links News
DocGo Inc. Recovery Likely Here’s What Data ShowsReliable Alerts for Daily Stock Movers Released - metal.it
DocGo Inc. At Decision Level — Rebound or ResistanceBuy Alerts With Low Risk Confirmation Noted - beatles.ru
DocGo Launches Mobile Health Vaccination Program in San Diego for Underserved Communities - AInvest
Bull Of The Day: OptimizeRX (OPRX) - The Globe and Mail
DocGo secures vaccination services contract with San Diego County By Investing.com - Investing.com South Africa
DocGo secures vaccination services contract with San Diego County - Investing.com
DocGo Launches Mobile Health Vaccination Program for the County of San Diego - Business Wire
What institutional investors are buying DocGo Inc. stockBuild a portfolio that outperforms the market - jammulinksnews.com
What are DocGo Inc. company’s key revenue driversInvest confidently with expert support - jammulinksnews.com
Docgo Inc Azioni (DCGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Docgo Inc Azioni (DCGO) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Burdiek Michael J | Director |
May 15 '25 |
Buy |
1.43 |
15,000 |
21,450 |
631,560 |
Klasko Stephen K. M.D. | Director |
May 14 '25 |
Buy |
1.49 |
15,000 |
22,350 |
15,000 |
Sugrue Stephen | Chief Compliance Officer |
May 14 '25 |
Buy |
1.44 |
10,000 |
14,400 |
357,328 |
ROSENBERG NORMAN | CFO and Treasurer |
May 14 '25 |
Buy |
1.47 |
15,000 |
22,050 |
871,272 |
Bienstock Lee | Chief Executive Officer |
May 14 '25 |
Buy |
1.54 |
15,000 |
23,100 |
1,971,079 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):